nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—THRB—breast cancer	0.22	0.632	CbGaD
Amiodarone—EBP—Raloxifene—breast cancer	0.0615	0.148	CbGbCtD
Amiodarone—CYP1A1—breast cancer	0.044	0.126	CbGaD
Amiodarone—EBP—Tamoxifen—breast cancer	0.0407	0.098	CbGbCtD
Amiodarone—CYP2D6—breast cancer	0.0327	0.094	CbGaD
Amiodarone—CYP3A4—breast cancer	0.0281	0.0806	CbGaD
Amiodarone—SIGMAR1—Raloxifene—breast cancer	0.0264	0.0637	CbGbCtD
Amiodarone—CYP2A6—Letrozole—breast cancer	0.0244	0.0587	CbGbCtD
Amiodarone—ABCB1—breast cancer	0.0234	0.0671	CbGaD
Amiodarone—SIGMAR1—Tamoxifen—breast cancer	0.0175	0.0421	CbGbCtD
Amiodarone—CYP1A1—Toremifene—breast cancer	0.017	0.0409	CbGbCtD
Amiodarone—CYP1A2—Anastrozole—breast cancer	0.00828	0.02	CbGbCtD
Amiodarone—CYP1A2—Toremifene—breast cancer	0.00758	0.0183	CbGbCtD
Amiodarone—CYP2C9—Anastrozole—breast cancer	0.00746	0.018	CbGbCtD
Amiodarone—CYP3A5—Lapatinib—breast cancer	0.00743	0.0179	CbGbCtD
Amiodarone—CYP2A6—Tamoxifen—breast cancer	0.00725	0.0175	CbGbCtD
Amiodarone—CYP2C8—Lapatinib—breast cancer	0.00714	0.0172	CbGbCtD
Amiodarone—ABCB1—Toremifene—breast cancer	0.00663	0.016	CbGbCtD
Amiodarone—CYP1A1—Tamoxifen—breast cancer	0.0062	0.0149	CbGbCtD
Amiodarone—CYP2C19—Lapatinib—breast cancer	0.00599	0.0144	CbGbCtD
Amiodarone—CYP3A4—Exemestane—breast cancer	0.00573	0.0138	CbGbCtD
Amiodarone—CYP2C9—Idarubicin—breast cancer	0.00566	0.0136	CbGbCtD
Amiodarone—CYP2C8—Raloxifene—breast cancer	0.00541	0.013	CbGbCtD
Amiodarone—CYP2A6—Fluorouracil—breast cancer	0.00534	0.0129	CbGbCtD
Amiodarone—CYP2D6—Idarubicin—breast cancer	0.00517	0.0125	CbGbCtD
Amiodarone—CYP3A7—Tamoxifen—breast cancer	0.00496	0.0119	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00496	0.0119	CbGbCtD
Amiodarone—CYP3A4—Letrozole—breast cancer	0.00487	0.0117	CbGbCtD
Amiodarone—ABCB1—Lapatinib—breast cancer	0.00483	0.0116	CbGbCtD
Amiodarone—CYP3A4—Anastrozole—breast cancer	0.00434	0.0105	CbGbCtD
Amiodarone—CYP3A4—Toremifene—breast cancer	0.00397	0.00957	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00386	0.0093	CbGbCtD
Amiodarone—CYP3A7—Paclitaxel—breast cancer	0.00386	0.0093	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00381	0.00917	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—breast cancer	0.00381	0.00917	CbGbCtD
Amiodarone—CYP3A5—Tamoxifen—breast cancer	0.00372	0.00896	CbGbCtD
Amiodarone—CYP3A4—Fulvestrant—breast cancer	0.00369	0.00889	CbGbCtD
Amiodarone—CYP2C8—Tamoxifen—breast cancer	0.00358	0.00862	CbGbCtD
Amiodarone—CYP3A4—Thiotepa—breast cancer	0.00329	0.00793	CbGbCtD
Amiodarone—CYP2C9—Capecitabine—breast cancer	0.0031	0.00747	CbGbCtD
Amiodarone—CYP3A4—Ixabepilone—breast cancer	0.00301	0.00725	CbGbCtD
Amiodarone—CYP2C19—Tamoxifen—breast cancer	0.003	0.00723	CbGbCtD
Amiodarone—CYP3A4—Lapatinib—breast cancer	0.0029	0.00698	CbGbCtD
Amiodarone—CYP3A5—Paclitaxel—breast cancer	0.00289	0.00697	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—breast cancer	0.00286	0.00688	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—breast cancer	0.00279	0.00672	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00279	0.00672	CbGbCtD
Amiodarone—CYP2C8—Paclitaxel—breast cancer	0.00278	0.00671	CbGbCtD
Amiodarone—CYP1A2—Tamoxifen—breast cancer	0.00277	0.00667	CbGbCtD
Amiodarone—ABCB1—Vinorelbine—breast cancer	0.00268	0.00646	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—breast cancer	0.00263	0.00635	CbGbCtD
Amiodarone—CYP2D6—Vinorelbine—breast cancer	0.00253	0.00609	CbGbCtD
Amiodarone—CYP2C9—Tamoxifen—breast cancer	0.00249	0.00601	CbGbCtD
Amiodarone—ABCB1—Tamoxifen—breast cancer	0.00242	0.00583	CbGbCtD
Amiodarone—ABCB1—Mitoxantrone—breast cancer	0.00236	0.00569	CbGbCtD
Amiodarone—CYP2D6—Tamoxifen—breast cancer	0.00228	0.0055	CbGbCtD
Amiodarone—CYP3A4—Raloxifene—breast cancer	0.00219	0.00529	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—breast cancer	0.00209	0.00504	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—breast cancer	0.00209	0.00502	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—breast cancer	0.00204	0.00491	CbGbCtD
Amiodarone—CYP2C9—Paclitaxel—breast cancer	0.00194	0.00468	CbGbCtD
Amiodarone—ABCB1—Paclitaxel—breast cancer	0.00188	0.00454	CbGbCtD
Amiodarone—ABCB1—Irinotecan—breast cancer	0.00186	0.00448	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—breast cancer	0.00184	0.00443	CbGbCtD
Amiodarone—ABCB1—Vinblastine—breast cancer	0.00165	0.00398	CbGbCtD
Amiodarone—CYP3A4—Vinorelbine—breast cancer	0.00161	0.00387	CbGbCtD
Amiodarone—CYP2D6—Vinblastine—breast cancer	0.00156	0.00375	CbGbCtD
Amiodarone—CYP3A4—Tamoxifen—breast cancer	0.00145	0.00349	CbGbCtD
Amiodarone—CYP3A4—Mitoxantrone—breast cancer	0.00141	0.00341	CbGbCtD
Amiodarone—ABCB1—Docetaxel—breast cancer	0.00136	0.00328	CbGbCtD
Amiodarone—THRB—mammary gland—breast cancer	0.00127	0.0444	CbGeAlD
Amiodarone—CACNA2D2—mammary gland—breast cancer	0.00126	0.0439	CbGeAlD
Amiodarone—CYP3A4—Paclitaxel—breast cancer	0.00113	0.00272	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—breast cancer	0.00111	0.00268	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—breast cancer	0.00102	0.00245	CbGbCtD
Amiodarone—EBP—uterus—breast cancer	0.000995	0.0347	CbGeAlD
Amiodarone—CYP3A4—Vinblastine—breast cancer	0.00099	0.00239	CbGbCtD
Amiodarone—ABCB1—Methotrexate—breast cancer	0.000984	0.00237	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—breast cancer	0.000957	0.00231	CbGbCtD
Amiodarone—EBP—female reproductive system—breast cancer	0.000894	0.0312	CbGeAlD
Amiodarone—CYP3A4—Docetaxel—breast cancer	0.000816	0.00197	CbGbCtD
Amiodarone—EBP—endocrine gland—breast cancer	0.000757	0.0264	CbGeAlD
Amiodarone—CYP3A4—Doxorubicin—breast cancer	0.000608	0.00147	CbGbCtD
Amiodarone—SIGMAR1—mammary gland—breast cancer	0.000583	0.0203	CbGeAlD
Amiodarone—THRB—pituitary gland—breast cancer	0.000576	0.0201	CbGeAlD
Amiodarone—THRA—adipose tissue—breast cancer	0.000574	0.02	CbGeAlD
Amiodarone—THRB—adipose tissue—breast cancer	0.000574	0.02	CbGeAlD
Amiodarone—CACNA2D2—pituitary gland—breast cancer	0.00057	0.0199	CbGeAlD
Amiodarone—Lucanthone—TOP2A—breast cancer	0.000563	0.206	CrCbGaD
Amiodarone—THRA—female reproductive system—breast cancer	0.000527	0.0184	CbGeAlD
Amiodarone—THRB—female reproductive system—breast cancer	0.000527	0.0184	CbGeAlD
Amiodarone—THRA—adrenal gland—breast cancer	0.000514	0.0179	CbGeAlD
Amiodarone—THRB—adrenal gland—breast cancer	0.000514	0.0179	CbGeAlD
Amiodarone—CACNA2D2—adrenal gland—breast cancer	0.000509	0.0177	CbGeAlD
Amiodarone—Proparacaine—SCN10A—breast cancer	0.000493	0.18	CrCbGaD
Amiodarone—SIGMAR1—nipple—breast cancer	0.000482	0.0168	CbGeAlD
Amiodarone—THRB—female gonad—breast cancer	0.00048	0.0167	CbGeAlD
Amiodarone—THRA—female gonad—breast cancer	0.00048	0.0167	CbGeAlD
Amiodarone—CACNA1H—uterus—breast cancer	0.000471	0.0164	CbGeAlD
Amiodarone—CACNA1H—pituitary gland—breast cancer	0.000462	0.0161	CbGeAlD
Amiodarone—Oxybuprocaine—SCN10A—breast cancer	0.000451	0.165	CrCbGaD
Amiodarone—THRA—endocrine gland—breast cancer	0.000446	0.0155	CbGeAlD
Amiodarone—THRB—endocrine gland—breast cancer	0.000446	0.0155	CbGeAlD
Amiodarone—CACNA2D2—endocrine gland—breast cancer	0.000441	0.0154	CbGeAlD
Amiodarone—CYP2C8—mammary gland—breast cancer	0.000425	0.0148	CbGeAlD
Amiodarone—CACNA1H—female reproductive system—breast cancer	0.000423	0.0147	CbGeAlD
Amiodarone—CACNA1H—adrenal gland—breast cancer	0.000413	0.0144	CbGeAlD
Amiodarone—Cinchocaine—SCN10A—breast cancer	0.0004	0.146	CrCbGaD
Amiodarone—CACNA1H—female gonad—breast cancer	0.000385	0.0134	CbGeAlD
Amiodarone—KCNH2—nipple—breast cancer	0.000384	0.0134	CbGeAlD
Amiodarone—CYP3A7—endocrine gland—breast cancer	0.000381	0.0133	CbGeAlD
Amiodarone—CYP2C9—mammary gland—breast cancer	0.000377	0.0131	CbGeAlD
Amiodarone—EBP—Azacitidine—Gemcitabine—breast cancer	0.000359	1	CbGdCrCtD
Amiodarone—CACNA1H—endocrine gland—breast cancer	0.000358	0.0125	CbGeAlD
Amiodarone—CYP2A6—adipose tissue—breast cancer	0.000341	0.0119	CbGeAlD
Amiodarone—CYP1A2—nipple—breast cancer	0.000329	0.0115	CbGeAlD
Amiodarone—CYP1A1—nipple—breast cancer	0.000324	0.0113	CbGeAlD
Amiodarone—THRB—lymph node—breast cancer	0.000308	0.0107	CbGeAlD
Amiodarone—THRA—lymph node—breast cancer	0.000308	0.0107	CbGeAlD
Amiodarone—CACNA2D2—lymph node—breast cancer	0.000305	0.0106	CbGeAlD
Amiodarone—SIGMAR1—endometrium—breast cancer	0.000291	0.0101	CbGeAlD
Amiodarone—ADRB1—adipose tissue—breast cancer	0.000274	0.00953	CbGeAlD
Amiodarone—SIGMAR1—uterus—breast cancer	0.000268	0.00935	CbGeAlD
Amiodarone—SIGMAR1—pituitary gland—breast cancer	0.000264	0.00918	CbGeAlD
Amiodarone—SIGMAR1—adipose tissue—breast cancer	0.000263	0.00915	CbGeAlD
Amiodarone—Oxybuprocaine—BCHE—breast cancer	0.000253	0.0923	CrCbGaD
Amiodarone—ADRB1—female reproductive system—breast cancer	0.000252	0.00876	CbGeAlD
Amiodarone—CACNA1H—lymph node—breast cancer	0.000247	0.00862	CbGeAlD
Amiodarone—SIGMAR1—adrenal gland—breast cancer	0.000236	0.0082	CbGeAlD
Amiodarone—KCNH2—endometrium—breast cancer	0.000232	0.00808	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—breast cancer	0.000228	0.00794	CbGeAlD
Amiodarone—Cinchocaine—BCHE—breast cancer	0.000224	0.0819	CrCbGaD
Amiodarone—SIGMAR1—female gonad—breast cancer	0.00022	0.00765	CbGeAlD
Amiodarone—CYP1A1—epithelium—breast cancer	0.000218	0.00761	CbGeAlD
Amiodarone—KCNH2—uterus—breast cancer	0.000214	0.00744	CbGeAlD
Amiodarone—ADRB1—endocrine gland—breast cancer	0.000213	0.00742	CbGeAlD
Amiodarone—CYP2C8—endometrium—breast cancer	0.000212	0.00739	CbGeAlD
Amiodarone—KCNH2—pituitary gland—breast cancer	0.00021	0.00731	CbGeAlD
Amiodarone—CYP1A1—skin of body—breast cancer	0.000208	0.00724	CbGeAlD
Amiodarone—KCNH2—female reproductive system—breast cancer	0.000192	0.00669	CbGeAlD
Amiodarone—CYP2C8—pituitary gland—breast cancer	0.000192	0.00669	CbGeAlD
Amiodarone—KCNH2—adrenal gland—breast cancer	0.000187	0.00653	CbGeAlD
Amiodarone—KCNH2—bone marrow—breast cancer	0.000181	0.00632	CbGeAlD
Amiodarone—CYP1A1—uterus—breast cancer	0.00018	0.00629	CbGeAlD
Amiodarone—CYP1A1—adipose tissue—breast cancer	0.000176	0.00615	CbGeAlD
Amiodarone—CYP2C8—female reproductive system—breast cancer	0.000176	0.00612	CbGeAlD
Amiodarone—KCNH2—female gonad—breast cancer	0.000175	0.00609	CbGeAlD
Amiodarone—CYP3A5—adipose tissue—breast cancer	0.000173	0.00601	CbGeAlD
Amiodarone—CYP2C19—endocrine gland—breast cancer	0.00017	0.00594	CbGeAlD
Amiodarone—KCNH2—endocrine gland—breast cancer	0.000163	0.00566	CbGeAlD
Amiodarone—CYP1A1—female reproductive system—breast cancer	0.000162	0.00565	CbGeAlD
Amiodarone—CYP2C9—female reproductive system—breast cancer	0.000156	0.00544	CbGeAlD
Amiodarone—CYP2C8—endocrine gland—breast cancer	0.000149	0.00518	CbGeAlD
Amiodarone—CYP1A1—female gonad—breast cancer	0.000148	0.00514	CbGeAlD
Amiodarone—CYP3A5—female gonad—breast cancer	0.000144	0.00503	CbGeAlD
Amiodarone—SIGMAR1—lymph node—breast cancer	0.000141	0.00492	CbGeAlD
Amiodarone—CYP1A2—endocrine gland—breast cancer	0.000139	0.00485	CbGeAlD
Amiodarone—ABCB1—embryo—breast cancer	0.000139	0.00484	CbGeAlD
Amiodarone—CYP1A1—endocrine gland—breast cancer	0.000137	0.00478	CbGeAlD
Amiodarone—CYP3A5—endocrine gland—breast cancer	0.000134	0.00468	CbGeAlD
Amiodarone—CYP2C9—endocrine gland—breast cancer	0.000132	0.0046	CbGeAlD
Amiodarone—CYP3A4—female reproductive system—breast cancer	0.000119	0.00415	CbGeAlD
Amiodarone—CYP2D6—female reproductive system—breast cancer	0.000117	0.00408	CbGeAlD
Amiodarone—ABCB1—epithelium—breast cancer	0.000113	0.00395	CbGeAlD
Amiodarone—KCNH2—lymph node—breast cancer	0.000112	0.00391	CbGeAlD
Amiodarone—CYP2D6—female gonad—breast cancer	0.000107	0.00371	CbGeAlD
Amiodarone—Dronedarone—CYP2D6—breast cancer	0.000106	0.0388	CrCbGaD
Amiodarone—ABCB1—endometrium—breast cancer	0.000102	0.00354	CbGeAlD
Amiodarone—CYP3A4—endocrine gland—breast cancer	0.000101	0.00351	CbGeAlD
Amiodarone—CYP2D6—endocrine gland—breast cancer	9.91e-05	0.00345	CbGeAlD
Amiodarone—CYP1A1—lymph node—breast cancer	9.49e-05	0.00331	CbGeAlD
Amiodarone—ABCB1—uterus—breast cancer	9.37e-05	0.00327	CbGeAlD
Amiodarone—ABCB1—pituitary gland—breast cancer	9.2e-05	0.00321	CbGeAlD
Amiodarone—ABCB1—adipose tissue—breast cancer	9.17e-05	0.00319	CbGeAlD
Amiodarone—Dronedarone—CYP3A4—breast cancer	9.1e-05	0.0333	CrCbGaD
Amiodarone—ABCB1—female reproductive system—breast cancer	8.43e-05	0.00294	CbGeAlD
Amiodarone—ABCB1—adrenal gland—breast cancer	8.22e-05	0.00286	CbGeAlD
Amiodarone—ABCB1—bone marrow—breast cancer	7.95e-05	0.00277	CbGeAlD
Amiodarone—Dronedarone—ALB—breast cancer	7.94e-05	0.029	CrCbGaD
Amiodarone—ABCB1—female gonad—breast cancer	7.67e-05	0.00267	CbGeAlD
Amiodarone—Dronedarone—ABCB1—breast cancer	7.58e-05	0.0277	CrCbGaD
Amiodarone—ABCB1—endocrine gland—breast cancer	7.13e-05	0.00248	CbGeAlD
Amiodarone—ABCB1—lymph node—breast cancer	4.93e-05	0.00172	CbGeAlD
Amiodarone—Renal failure—Doxorubicin—breast cancer	2.17e-05	0.000173	CcSEcCtD
Amiodarone—Infection—Capecitabine—breast cancer	2.17e-05	0.000173	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—breast cancer	2.17e-05	0.000172	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—breast cancer	2.17e-05	0.000172	CcSEcCtD
Amiodarone—Dizziness—Irinotecan—breast cancer	2.16e-05	0.000172	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—breast cancer	2.15e-05	0.000171	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—breast cancer	2.15e-05	0.000171	CcSEcCtD
Amiodarone—Shock—Capecitabine—breast cancer	2.15e-05	0.000171	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—breast cancer	2.14e-05	0.00017	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—breast cancer	2.14e-05	0.00017	CcSEcCtD
Amiodarone—Thrombocytopenia—Capecitabine—breast cancer	2.14e-05	0.00017	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—breast cancer	2.14e-05	0.00017	CcSEcCtD
Amiodarone—Tachycardia—Capecitabine—breast cancer	2.13e-05	0.00017	CcSEcCtD
Amiodarone—Skin disorder—Capecitabine—breast cancer	2.12e-05	0.000169	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—breast cancer	2.12e-05	0.000168	CcSEcCtD
Amiodarone—Urticaria—Paclitaxel—breast cancer	2.12e-05	0.000168	CcSEcCtD
Amiodarone—Hyperhidrosis—Capecitabine—breast cancer	2.11e-05	0.000168	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—breast cancer	2.11e-05	0.000168	CcSEcCtD
Amiodarone—Abdominal pain—Paclitaxel—breast cancer	2.11e-05	0.000167	CcSEcCtD
Amiodarone—Body temperature increased—Paclitaxel—breast cancer	2.11e-05	0.000167	CcSEcCtD
Amiodarone—Anorexia—Capecitabine—breast cancer	2.08e-05	0.000166	CcSEcCtD
Amiodarone—Vomiting—Mitoxantrone—breast cancer	2.08e-05	0.000165	CcSEcCtD
Amiodarone—Vomiting—Irinotecan—breast cancer	2.08e-05	0.000165	CcSEcCtD
Amiodarone—Dizziness—Fluorouracil—breast cancer	2.07e-05	0.000165	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—breast cancer	2.07e-05	0.000164	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—breast cancer	2.06e-05	0.000164	CcSEcCtD
Amiodarone—Rash—Mitoxantrone—breast cancer	2.06e-05	0.000164	CcSEcCtD
Amiodarone—Rash—Irinotecan—breast cancer	2.06e-05	0.000164	CcSEcCtD
Amiodarone—Dermatitis—Irinotecan—breast cancer	2.06e-05	0.000164	CcSEcCtD
Amiodarone—Dermatitis—Mitoxantrone—breast cancer	2.06e-05	0.000164	CcSEcCtD
Amiodarone—Headache—Mitoxantrone—breast cancer	2.05e-05	0.000163	CcSEcCtD
Amiodarone—Headache—Irinotecan—breast cancer	2.05e-05	0.000163	CcSEcCtD
Amiodarone—Hypotension—Capecitabine—breast cancer	2.04e-05	0.000162	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—breast cancer	2.04e-05	0.000162	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—breast cancer	2.03e-05	0.000161	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—breast cancer	2.03e-05	0.000161	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—breast cancer	2.02e-05	0.000161	CcSEcCtD
Amiodarone—Vomiting—Gemcitabine—breast cancer	2.02e-05	0.000161	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—breast cancer	2.02e-05	0.000161	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—breast cancer	2.01e-05	0.00016	CcSEcCtD
Amiodarone—Rash—Gemcitabine—breast cancer	2.01e-05	0.00016	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—breast cancer	2e-05	0.000159	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—breast cancer	2e-05	0.000159	CcSEcCtD
Amiodarone—Erythema—Methotrexate—breast cancer	1.99e-05	0.000159	CcSEcCtD
Amiodarone—Headache—Gemcitabine—breast cancer	1.99e-05	0.000159	CcSEcCtD
Amiodarone—Flushing—Epirubicin—breast cancer	1.99e-05	0.000158	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—breast cancer	1.99e-05	0.000158	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—breast cancer	1.99e-05	0.000158	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—breast cancer	1.98e-05	0.000158	CcSEcCtD
Amiodarone—Insomnia—Capecitabine—breast cancer	1.98e-05	0.000157	CcSEcCtD
Amiodarone—Rash—Fluorouracil—breast cancer	1.97e-05	0.000157	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—breast cancer	1.97e-05	0.000157	CcSEcCtD
Amiodarone—Paraesthesia—Capecitabine—breast cancer	1.96e-05	0.000156	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—breast cancer	1.96e-05	0.000156	CcSEcCtD
Amiodarone—Hypersensitivity—Paclitaxel—breast cancer	1.96e-05	0.000156	CcSEcCtD
Amiodarone—Headache—Fluorouracil—breast cancer	1.96e-05	0.000156	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—breast cancer	1.95e-05	0.000155	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—breast cancer	1.95e-05	0.000155	CcSEcCtD
Amiodarone—Dyspnoea—Capecitabine—breast cancer	1.95e-05	0.000155	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—breast cancer	1.95e-05	0.000155	CcSEcCtD
Amiodarone—Nausea—Mitoxantrone—breast cancer	1.94e-05	0.000154	CcSEcCtD
Amiodarone—Nausea—Irinotecan—breast cancer	1.94e-05	0.000154	CcSEcCtD
Amiodarone—Constipation—Docetaxel—breast cancer	1.93e-05	0.000154	CcSEcCtD
Amiodarone—Pain—Docetaxel—breast cancer	1.93e-05	0.000154	CcSEcCtD
Amiodarone—Back pain—Methotrexate—breast cancer	1.93e-05	0.000153	CcSEcCtD
Amiodarone—Dyspepsia—Capecitabine—breast cancer	1.92e-05	0.000153	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—breast cancer	1.91e-05	0.000152	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—breast cancer	1.91e-05	0.000152	CcSEcCtD
Amiodarone—Asthenia—Paclitaxel—breast cancer	1.91e-05	0.000152	CcSEcCtD
Amiodarone—Decreased appetite—Capecitabine—breast cancer	1.9e-05	0.000151	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—breast cancer	1.89e-05	0.000151	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—breast cancer	1.89e-05	0.00015	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Capecitabine—breast cancer	1.89e-05	0.00015	CcSEcCtD
Amiodarone—Fatigue—Capecitabine—breast cancer	1.88e-05	0.00015	CcSEcCtD
Amiodarone—Pruritus—Paclitaxel—breast cancer	1.88e-05	0.00015	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—breast cancer	1.88e-05	0.000149	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—breast cancer	1.88e-05	0.000149	CcSEcCtD
Amiodarone—Pain—Capecitabine—breast cancer	1.87e-05	0.000149	CcSEcCtD
Amiodarone—Constipation—Capecitabine—breast cancer	1.87e-05	0.000149	CcSEcCtD
Amiodarone—Erythema—Epirubicin—breast cancer	1.87e-05	0.000148	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—breast cancer	1.86e-05	0.000148	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—breast cancer	1.86e-05	0.000148	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—breast cancer	1.85e-05	0.000147	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—breast cancer	1.85e-05	0.000147	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—breast cancer	1.85e-05	0.000147	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—breast cancer	1.84e-05	0.000146	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—breast cancer	1.83e-05	0.000145	CcSEcCtD
Amiodarone—Diarrhoea—Paclitaxel—breast cancer	1.82e-05	0.000145	CcSEcCtD
Amiodarone—Back pain—Epirubicin—breast cancer	1.81e-05	0.000144	CcSEcCtD
Amiodarone—Feeling abnormal—Capecitabine—breast cancer	1.8e-05	0.000143	CcSEcCtD
Amiodarone—Malaise—Methotrexate—breast cancer	1.8e-05	0.000143	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—breast cancer	1.79e-05	0.000142	CcSEcCtD
Amiodarone—Gastrointestinal pain—Capecitabine—breast cancer	1.79e-05	0.000142	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—breast cancer	1.78e-05	0.000142	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—breast cancer	1.78e-05	0.000142	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—breast cancer	1.77e-05	0.000141	CcSEcCtD
Amiodarone—Dizziness—Paclitaxel—breast cancer	1.76e-05	0.00014	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—breast cancer	1.76e-05	0.00014	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—breast cancer	1.75e-05	0.000139	CcSEcCtD
Amiodarone—Cough—Methotrexate—breast cancer	1.74e-05	0.000138	CcSEcCtD
Amiodarone—Urticaria—Capecitabine—breast cancer	1.74e-05	0.000138	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—breast cancer	1.73e-05	0.000138	CcSEcCtD
Amiodarone—Abdominal pain—Capecitabine—breast cancer	1.73e-05	0.000137	CcSEcCtD
Amiodarone—Body temperature increased—Capecitabine—breast cancer	1.73e-05	0.000137	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—breast cancer	1.73e-05	0.000137	CcSEcCtD
Amiodarone—Agitation—Epirubicin—breast cancer	1.71e-05	0.000136	CcSEcCtD
Amiodarone—Vomiting—Paclitaxel—breast cancer	1.69e-05	0.000135	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—breast cancer	1.69e-05	0.000134	CcSEcCtD
Amiodarone—Malaise—Epirubicin—breast cancer	1.68e-05	0.000134	CcSEcCtD
Amiodarone—Rash—Paclitaxel—breast cancer	1.68e-05	0.000134	CcSEcCtD
Amiodarone—Dermatitis—Paclitaxel—breast cancer	1.68e-05	0.000133	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—breast cancer	1.68e-05	0.000133	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—breast cancer	1.68e-05	0.000133	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—breast cancer	1.67e-05	0.000133	CcSEcCtD
Amiodarone—Headache—Paclitaxel—breast cancer	1.67e-05	0.000133	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—breast cancer	1.66e-05	0.000132	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—breast cancer	1.64e-05	0.000131	CcSEcCtD
Amiodarone—Cough—Epirubicin—breast cancer	1.63e-05	0.00013	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—breast cancer	1.63e-05	0.000129	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—breast cancer	1.63e-05	0.000129	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—breast cancer	1.62e-05	0.000129	CcSEcCtD
Amiodarone—Infection—Methotrexate—breast cancer	1.62e-05	0.000129	CcSEcCtD
Amiodarone—Hypersensitivity—Capecitabine—breast cancer	1.61e-05	0.000128	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—breast cancer	1.6e-05	0.000127	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—breast cancer	1.6e-05	0.000127	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—breast cancer	1.59e-05	0.000127	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—breast cancer	1.59e-05	0.000126	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—breast cancer	1.58e-05	0.000126	CcSEcCtD
Amiodarone—Nausea—Paclitaxel—breast cancer	1.58e-05	0.000126	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—breast cancer	1.58e-05	0.000126	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—breast cancer	1.57e-05	0.000125	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—breast cancer	1.57e-05	0.000125	CcSEcCtD
Amiodarone—Asthenia—Capecitabine—breast cancer	1.57e-05	0.000125	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—breast cancer	1.56e-05	0.000124	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—breast cancer	1.55e-05	0.000124	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—breast cancer	1.55e-05	0.000123	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—breast cancer	1.55e-05	0.000123	CcSEcCtD
Amiodarone—Pruritus—Capecitabine—breast cancer	1.55e-05	0.000123	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—breast cancer	1.54e-05	0.000123	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—breast cancer	1.54e-05	0.000122	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—breast cancer	1.52e-05	0.000121	CcSEcCtD
Amiodarone—Oedema—Epirubicin—breast cancer	1.52e-05	0.000121	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—breast cancer	1.52e-05	0.000121	CcSEcCtD
Amiodarone—Infection—Epirubicin—breast cancer	1.51e-05	0.00012	CcSEcCtD
Amiodarone—Cough—Doxorubicin—breast cancer	1.51e-05	0.00012	CcSEcCtD
Amiodarone—Shock—Epirubicin—breast cancer	1.5e-05	0.000119	CcSEcCtD
Amiodarone—Diarrhoea—Capecitabine—breast cancer	1.5e-05	0.000119	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—breast cancer	1.49e-05	0.000119	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—breast cancer	1.49e-05	0.000119	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—breast cancer	1.49e-05	0.000118	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—breast cancer	1.48e-05	0.000118	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—breast cancer	1.47e-05	0.000117	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—breast cancer	1.47e-05	0.000117	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—breast cancer	1.46e-05	0.000117	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—breast cancer	1.46e-05	0.000116	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—breast cancer	1.45e-05	0.000116	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—breast cancer	1.45e-05	0.000115	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—breast cancer	1.45e-05	0.000115	CcSEcCtD
Amiodarone—Dizziness—Capecitabine—breast cancer	1.45e-05	0.000115	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—breast cancer	1.44e-05	0.000114	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—breast cancer	1.44e-05	0.000114	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—breast cancer	1.43e-05	0.000114	CcSEcCtD
Amiodarone—Rash—Docetaxel—breast cancer	1.42e-05	0.000113	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—breast cancer	1.42e-05	0.000113	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—breast cancer	1.42e-05	0.000113	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—breast cancer	1.42e-05	0.000113	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—breast cancer	1.41e-05	0.000113	CcSEcCtD
Amiodarone—Headache—Docetaxel—breast cancer	1.41e-05	0.000112	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—breast cancer	1.41e-05	0.000112	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—breast cancer	1.41e-05	0.000112	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—breast cancer	1.4e-05	0.000112	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—breast cancer	1.4e-05	0.000112	CcSEcCtD
Amiodarone—Infection—Doxorubicin—breast cancer	1.4e-05	0.000111	CcSEcCtD
Amiodarone—Pain—Methotrexate—breast cancer	1.39e-05	0.000111	CcSEcCtD
Amiodarone—Vomiting—Capecitabine—breast cancer	1.39e-05	0.000111	CcSEcCtD
Amiodarone—Shock—Doxorubicin—breast cancer	1.39e-05	0.00011	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—breast cancer	1.38e-05	0.00011	CcSEcCtD
Amiodarone—Rash—Capecitabine—breast cancer	1.38e-05	0.00011	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—breast cancer	1.38e-05	0.00011	CcSEcCtD
Amiodarone—Dermatitis—Capecitabine—breast cancer	1.38e-05	0.00011	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—breast cancer	1.38e-05	0.000109	CcSEcCtD
Amiodarone—Headache—Capecitabine—breast cancer	1.37e-05	0.000109	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—breast cancer	1.37e-05	0.000109	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—breast cancer	1.37e-05	0.000109	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—breast cancer	1.36e-05	0.000108	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—breast cancer	1.36e-05	0.000108	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—breast cancer	1.34e-05	0.000107	CcSEcCtD
Amiodarone—Nausea—Docetaxel—breast cancer	1.34e-05	0.000107	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—breast cancer	1.34e-05	0.000107	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—breast cancer	1.34e-05	0.000107	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—breast cancer	1.33e-05	0.000106	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—breast cancer	1.32e-05	0.000105	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—breast cancer	1.32e-05	0.000105	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—breast cancer	1.31e-05	0.000105	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—breast cancer	1.31e-05	0.000104	CcSEcCtD
Amiodarone—Constipation—Epirubicin—breast cancer	1.3e-05	0.000104	CcSEcCtD
Amiodarone—Pain—Epirubicin—breast cancer	1.3e-05	0.000104	CcSEcCtD
Amiodarone—Nausea—Capecitabine—breast cancer	1.3e-05	0.000103	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—breast cancer	1.29e-05	0.000103	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—breast cancer	1.29e-05	0.000102	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—breast cancer	1.29e-05	0.000102	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—breast cancer	1.27e-05	0.000101	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—breast cancer	1.27e-05	0.000101	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—breast cancer	1.26e-05	9.99e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—breast cancer	1.26e-05	9.98e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—breast cancer	1.25e-05	9.9e-05	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—breast cancer	1.24e-05	9.87e-05	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—breast cancer	1.22e-05	9.74e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.22e-05	9.68e-05	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—breast cancer	1.21e-05	9.66e-05	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—breast cancer	1.21e-05	9.62e-05	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—breast cancer	1.21e-05	9.58e-05	CcSEcCtD
Amiodarone—Pain—Doxorubicin—breast cancer	1.21e-05	9.58e-05	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—breast cancer	1.2e-05	9.57e-05	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—breast cancer	1.2e-05	9.57e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—breast cancer	1.2e-05	9.54e-05	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—breast cancer	1.17e-05	9.29e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—breast cancer	1.16e-05	9.24e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—breast cancer	1.15e-05	9.16e-05	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—breast cancer	1.15e-05	9.16e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—breast cancer	1.12e-05	8.92e-05	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—breast cancer	1.12e-05	8.9e-05	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—breast cancer	1.11e-05	8.86e-05	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—breast cancer	1.11e-05	8.86e-05	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—breast cancer	1.11e-05	8.86e-05	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—breast cancer	1.09e-05	8.69e-05	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—breast cancer	1.08e-05	8.57e-05	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—breast cancer	1.08e-05	8.56e-05	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—breast cancer	1.04e-05	8.29e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—breast cancer	1.04e-05	8.26e-05	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—breast cancer	1.03e-05	8.23e-05	CcSEcCtD
Amiodarone—Rash—Methotrexate—breast cancer	1.03e-05	8.16e-05	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—breast cancer	1.03e-05	8.15e-05	CcSEcCtD
Amiodarone—Headache—Methotrexate—breast cancer	1.02e-05	8.11e-05	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—breast cancer	1.01e-05	8.04e-05	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—breast cancer	1.01e-05	8.01e-05	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—breast cancer	9.97e-06	7.93e-05	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—breast cancer	9.68e-06	7.7e-05	CcSEcCtD
Amiodarone—Nausea—Methotrexate—breast cancer	9.67e-06	7.69e-05	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—breast cancer	9.64e-06	7.67e-05	CcSEcCtD
Amiodarone—Rash—Epirubicin—breast cancer	9.6e-06	7.64e-05	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—breast cancer	9.59e-06	7.63e-05	CcSEcCtD
Amiodarone—Headache—Epirubicin—breast cancer	9.54e-06	7.59e-05	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—breast cancer	9.32e-06	7.41e-05	CcSEcCtD
Amiodarone—Nausea—Epirubicin—breast cancer	9.05e-06	7.19e-05	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—breast cancer	8.96e-06	7.13e-05	CcSEcCtD
Amiodarone—Rash—Doxorubicin—breast cancer	8.89e-06	7.07e-05	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—breast cancer	8.88e-06	7.06e-05	CcSEcCtD
Amiodarone—Headache—Doxorubicin—breast cancer	8.83e-06	7.02e-05	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—breast cancer	8.37e-06	6.66e-05	CcSEcCtD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—breast cancer	1.28e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA3—breast cancer	1.28e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—breast cancer	1.28e-06	1.61e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—breast cancer	1.27e-06	1.61e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NQO1—breast cancer	1.27e-06	1.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.27e-06	1.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A2—breast cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—breast cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NOS3—breast cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—breast cancer	1.26e-06	1.6e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—COMT—breast cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NCOR1—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—COMT—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAV1—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.25e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCG2—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CPT1A—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTR—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP3A4—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—breast cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—breast cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HMOX1—breast cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ITPR1—breast cancer	1.23e-06	1.56e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HMOX1—breast cancer	1.23e-06	1.55e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ITPR1—breast cancer	1.22e-06	1.55e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PLA2G4A—breast cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—breast cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NCOR1—breast cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1B1—breast cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HPGDS—breast cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOS3—breast cancer	1.21e-06	1.53e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HBA1—breast cancer	1.21e-06	1.53e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—breast cancer	1.2e-06	1.52e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPX1—breast cancer	1.2e-06	1.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.2e-06	1.51e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.19e-06	1.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A1—breast cancer	1.19e-06	1.5e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—breast cancer	1.19e-06	1.5e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ACHE—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPX1—breast cancer	1.17e-06	1.48e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—breast cancer	1.17e-06	1.48e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—breast cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOA1—breast cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A1—breast cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—breast cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—breast cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NCOR1—breast cancer	1.15e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—breast cancer	1.15e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.15e-06	1.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP19A1—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—STK11—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAF1—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAV1—breast cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NCOR1—breast cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—breast cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RELA—breast cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—breast cancer	1.14e-06	1.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—breast cancer	1.13e-06	1.43e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP17A1—breast cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—breast cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO1—breast cancer	1.11e-06	1.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS1—breast cancer	1.11e-06	1.4e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—breast cancer	1.11e-06	1.4e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPX1—breast cancer	1.1e-06	1.39e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—breast cancer	1.1e-06	1.39e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPX1—breast cancer	1.09e-06	1.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.09e-06	1.38e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A1—breast cancer	1.09e-06	1.38e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2D6—breast cancer	1.09e-06	1.37e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—breast cancer	1.08e-06	1.37e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A1—breast cancer	1.08e-06	1.37e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—breast cancer	1.08e-06	1.37e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.08e-06	1.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.08e-06	1.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—breast cancer	1.07e-06	1.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—COMT—breast cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA2—breast cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—breast cancer	1.06e-06	1.34e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—breast cancer	1.06e-06	1.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.05e-06	1.33e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMOX1—breast cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ITPR1—breast cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—breast cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—breast cancer	1.04e-06	1.32e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.04e-06	1.31e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FASN—breast cancer	1.04e-06	1.31e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—breast cancer	1.03e-06	1.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—breast cancer	1.03e-06	1.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—breast cancer	1.03e-06	1.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAV1—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—breast cancer	1.01e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—breast cancer	1.01e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—breast cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—breast cancer	1e-06	1.27e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—breast cancer	1e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—breast cancer	1e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NOS3—breast cancer	1e-06	1.26e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAV1—breast cancer	9.98e-07	1.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—breast cancer	9.93e-07	1.25e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—breast cancer	9.88e-07	1.25e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—breast cancer	9.87e-07	1.25e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—breast cancer	9.84e-07	1.24e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NQO1—breast cancer	9.84e-07	1.24e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOR1—breast cancer	9.77e-07	1.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—breast cancer	9.77e-07	1.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PLA2G4A—breast cancer	9.77e-07	1.23e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.77e-07	1.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—breast cancer	9.73e-07	1.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—breast cancer	9.7e-07	1.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—breast cancer	9.68e-07	1.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK8—breast cancer	9.47e-07	1.2e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NOS3—breast cancer	9.44e-07	1.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—breast cancer	9.44e-07	1.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1B1—breast cancer	9.43e-07	1.19e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAV1—breast cancer	9.4e-07	1.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPX1—breast cancer	9.36e-07	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAV1—breast cancer	9.32e-07	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—breast cancer	9.31e-07	1.18e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1A1—breast cancer	9.26e-07	1.17e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.25e-07	1.17e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—breast cancer	9.23e-07	1.16e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—breast cancer	9.19e-07	1.16e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—breast cancer	9.17e-07	1.16e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—breast cancer	9.14e-07	1.15e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—breast cancer	9.09e-07	1.15e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—breast cancer	9.05e-07	1.14e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA1—breast cancer	9e-07	1.14e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—breast cancer	8.98e-07	1.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.9e-07	1.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STK11—breast cancer	8.87e-07	1.12e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP19A1—breast cancer	8.87e-07	1.12e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—breast cancer	8.74e-07	1.1e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—breast cancer	8.72e-07	1.1e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NOS3—breast cancer	8.66e-07	1.09e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—breast cancer	8.66e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—breast cancer	8.64e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—breast cancer	8.63e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—breast cancer	8.56e-07	1.08e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—breast cancer	8.49e-07	1.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—breast cancer	8.27e-07	1.04e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—COMT—breast cancer	8.24e-07	1.04e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—breast cancer	8.2e-07	1.04e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—breast cancer	8.18e-07	1.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMOX1—breast cancer	8.09e-07	1.02e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—breast cancer	8.08e-07	1.02e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ITPR1—breast cancer	8.07e-07	1.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—breast cancer	8.04e-07	1.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—breast cancer	8.02e-07	1.01e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—breast cancer	7.99e-07	1.01e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—breast cancer	7.99e-07	1.01e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—breast cancer	7.97e-07	1.01e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAV1—breast cancer	7.96e-07	1.01e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—breast cancer	7.92e-07	1e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—breast cancer	7.89e-07	9.96e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—breast cancer	7.87e-07	9.93e-06	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—breast cancer	7.78e-07	9.82e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—breast cancer	7.77e-07	9.81e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NOS3—breast cancer	7.73e-07	9.76e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—breast cancer	7.63e-07	9.63e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.61e-07	9.61e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NOS3—breast cancer	7.54e-07	9.52e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.54e-07	9.52e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOR1—breast cancer	7.54e-07	9.52e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—breast cancer	7.54e-07	9.52e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—breast cancer	7.53e-07	9.51e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—breast cancer	7.53e-07	9.5e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—breast cancer	7.46e-07	9.42e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—breast cancer	7.43e-07	9.38e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—breast cancer	7.43e-07	9.38e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—breast cancer	7.37e-07	9.3e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—breast cancer	7.25e-07	9.16e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPX1—breast cancer	7.22e-07	9.12e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A1—breast cancer	7.15e-07	9.02e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—breast cancer	7.13e-07	9.01e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—breast cancer	7.13e-07	9e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NOS3—breast cancer	7.11e-07	8.97e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—breast cancer	7.09e-07	8.95e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—breast cancer	7.07e-07	8.92e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NOS3—breast cancer	7.05e-07	8.9e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—breast cancer	6.96e-07	8.79e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—breast cancer	6.91e-07	8.72e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—breast cancer	6.9e-07	8.71e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—breast cancer	6.83e-07	8.62e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—breast cancer	6.66e-07	8.41e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—breast cancer	6.6e-07	8.34e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—breast cancer	6.56e-07	8.28e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—breast cancer	6.5e-07	8.21e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—breast cancer	6.5e-07	8.21e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—breast cancer	6.45e-07	8.14e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—breast cancer	6.38e-07	8.05e-06	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—breast cancer	6.36e-07	8.03e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—breast cancer	6.32e-07	7.97e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—breast cancer	6.3e-07	7.95e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—breast cancer	6.16e-07	7.78e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAV1—breast cancer	6.15e-07	7.76e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—breast cancer	6.05e-07	7.63e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NOS3—breast cancer	6.02e-07	7.6e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—breast cancer	6.02e-07	7.6e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—breast cancer	5.83e-07	7.36e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—breast cancer	5.67e-07	7.16e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—breast cancer	5.63e-07	7.1e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—breast cancer	5.62e-07	7.1e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—breast cancer	5.6e-07	7.07e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—breast cancer	5.58e-07	7.04e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—breast cancer	5.56e-07	7.02e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—breast cancer	5.51e-07	6.95e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—breast cancer	5.31e-07	6.71e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—breast cancer	4.92e-07	6.21e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—breast cancer	4.87e-07	6.15e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—breast cancer	4.86e-07	6.13e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—breast cancer	4.8e-07	6.06e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NOS3—breast cancer	4.65e-07	5.87e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—breast cancer	4.6e-07	5.8e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—breast cancer	4.35e-07	5.49e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—breast cancer	4.34e-07	5.48e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—breast cancer	4.29e-07	5.42e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—breast cancer	4.25e-07	5.37e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—breast cancer	4.24e-07	5.36e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—breast cancer	4e-07	5.05e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—breast cancer	3.98e-07	5.02e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—breast cancer	3.97e-07	5.01e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—breast cancer	3.71e-07	4.68e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—breast cancer	3.55e-07	4.49e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—breast cancer	3.47e-07	4.38e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—breast cancer	3.39e-07	4.28e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—breast cancer	3.27e-07	4.13e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—breast cancer	3.24e-07	4.09e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—breast cancer	2.77e-07	3.49e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—breast cancer	2.62e-07	3.3e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—breast cancer	2.14e-07	2.7e-06	CbGpPWpGaD
